MGC Pharmaceuticals Ltd's "historic" March quarter highlighted by LSE listing and record sales
MGC Pharmaceuticals’ “historic” March quarter highlighted by LSE listing and record sales MGC Pharma became the first medicinal cannabis company to list on the London Stock Exchange, amid record sales of its phytomedicines. CEO Roby Zomer says the company is now ready to capitalise on years of hard work. MGC Pharmaceuticals Ltd (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) (FRA:H5O) has completed arguably its best-ever quarter, with a London Stock Exchange (LSE) listing and record sales highlighting a busy period. The European-based biopharma company, developing and producing phytocan...
Source: proactiveinvestors.co.uk